Bio-Path Holdings, Inc. Made Headway
Fri, Oct 20, 2023 at 07:18 PM
Bio-Path Holdings, Inc. (BPTH:NASDAQ) rocketted at $0.69, representing a gain of 35.3%. From Fri, Oct 06, 2023, the stock recorded 40.00% Up Days and 45.45% Green Days
The stock spiked on Fri, Oct 13, 2023 at $1.08 with a volume of 123M+.
About Bio-Path Holdings, Inc. (BPTH:NASDAQ)
Bio-Path Holdings Inc is a clinical & preclinical stage oncology focused antisense drug development company utilizing novel technology achieving systemic delivery for specific protein inhibition for any gene product that is over-expressed in disease.
Top 10 Gainers:
- XORTX Therapeutics Inc. (XRTX:NASDAQ), 100.63%
- Golden Minerals Company (AUMN:NYSEMKT), 49.61%
- Wang & Lee Group Inc. (WLGS:NASDAQ), 38.69%
- Nouveau Monde Graphite Inc. (NMG:NYSE), 36.63%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 36.11%
- Bio-Path Holdings, Inc. (BPTH:NASDAQ), 35.32%
- Lipella Pharmaceuticals Inc. (LIPO:NASDAQ), 34.84%
- Aravive, Inc. (ARAV:NASDAQ), 31.75%
- FLJ Group Limited (FLJ:NASDAQ), 31.05%
- Northann Corp. (NCL:NYSEMKT), 30.43%